p53 overexpression in advanced-stage endometrial adenocarcinoma

American Journal of Obstetrics and Gynecology

Volumn 175, Issue 5, 1996, Pages 1246-1252

  Kohler, M F ^a   Carney, P ^a   Dodge, R ^a   Soper, J T ^a   Clarke Pearson, D L ^a   Marks, J R ^a   Berchuck, A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

p53 tumor suppresor gene; prognosis; race; survival; Uterine cancer

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RACE DIFFERENCE; RISK ASSESSMENT; TUMOR SUPPRESSOR GENE;

EID: 0029967895     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(96)70036-4     Document Type: Article

References (25)

1. A Berchuck J Boyd Molecular basis of endometrial cancer Cancer 76 1995 2034 2040
2. A Berchuck MF Kohler JR Marks R Wiseman J Boyd RC Bast Jr The p53 tumor suppressor gene frequently is altered in gynecologic cancers Am J Obstet Gynecol 170 1994 246 252
3. MF Kohler A Berchuck AM Davidoff Overexpression and mutation of p53 in endometrial carcinoma Cancer Res 52 1992 1622 1627
4. AS Lukes MF Kohler CF Pieper Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer Cancer 73 1994 2380 2385
5. BJ Kerns PA Jordan MB Moore p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry J Histochem Cytochem 40 1992 1047 1051
6. MF Kohler BJ Kerns PA Humphrey JR Marks RC Bast A Berchuck Mutation and overexpression of p53 in early-stage epithelial ovarian cancer Obstet Gynecol 81 1993 643 650
7. P Armitage Statistical methods in medical research 1971 Blackwell Scientific London 363 365
8. DW Hosmer S Lemeshow Applied logistic regression 1989 John Wiley New York 225 234
9. EL Kaplan P Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
10. N Mantel Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 50 1966 163 170
11. R Brookmeyer J Crowley A confidence interval for the median survival time Biometrics 38 1982 29 41
12. MF Kohler JR Marks RW Wiseman Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer J Natl Cancer Inst 85 1993 1513 1519
13. A Okamoto Y Sameshima Y Yamada Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus Cancer Res 51 1991 5632 5636
14. T Enomoto M Fujita M Inoue Alterations of the p53 tumor suppressor gene and its association with activation of the c-K- ras -2 protooncogene in premalignant and malignant lesions of the human uterine endometrium Cancer Res 53 1993 1883 1888
15. M Inoue A Okayama M Fujita Clinicopathological characteristics of p53 overexpression in endometrial cancers Int J Cancer 58 1994 14 19
16. K Ito K Watanabe S Nasim Prognostic significance of p53 overexpression in endometrial cancer Cancer Res 54 1994 4667 4670
17. CP Morrow BN Bundy RJ Kurman Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study Gynecol Oncol 40 1991 55 65
18. T Fujiwara EA Grimm T Mukhopadhyay WW Zhang LB Owen-Schaub JA. Roth Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene Cancer Res 54 1994 2287 2291
19. J Howard BF Hankey RS Greenberg A collaborative study of differences in the survival rates of black patients and white patients with cancer Cancer 69 1992 2349 2360
20. CL Kosary FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina Semin Surg Oncol 10 1994 31 46
21. RP Bain RS Greenberg KC Chung Racial differences in survival of women with endometrial cancer Am J Obstet Gynecol 157 1987 914 923
22. HA Hill RJ Coates H Austin Racial differences in tumor grade among women with endometrial cancer Gynecol Oncol 56 1995 154 163
23. JR Liu M Conaway JT Soper DL Clarke-Pearson A Berchuck Relationship between race and interval to treatment in endometrial cancer Obstet Gynecol 86 1995 486 490
24. LM Axtell MH Myers Contrasts in survival of black and white cancer patients, 1960-73 J Natl Cancer Inst 60 1978 1209 1215
25. JW Eley HA Hill VW Chen Racial differences in survival from breast cancer: results of the National Cancer Institute Black/White Cancer Survival Study JAMA 272 1994 947 954